Taken together, we suggest that AKR1C2 may promote LUAD by inhibiting ferroptosis, and AKR1C2 knockdown helps to promote ferroptosis in lung cancer cells, thereby inhibiting lung cancer progression. This evidence concerns the gene AKR1C2 and lung carcinoma.